Intensified Histopathological Work-Up after Pancreatic Head Resection Reveals Relevant Prognostic Markers.


Journal

Digestion
ISSN: 1421-9867
Titre abrégé: Digestion
Pays: Switzerland
ID NLM: 0150472

Informations de publication

Date de publication:
2021
Historique:
received: 25 03 2019
accepted: 07 11 2019
pubmed: 22 1 2020
medline: 19 8 2021
entrez: 22 1 2020
Statut: ppublish

Résumé

Local recurrence remains a major problem after pancreatic head resection. Intensified histopathological work-up of surgical specimens after pancreatic head resection has revealed an increased number of incomplete resections (R1) depending on tumor infiltration front at the resection margins (RMs). It remains unclear to which extent the increased R1 resection rate has a clinical relevance for the patients' prognosis. Pancreatic head resections between 2006 and 2012 were histologically intensively worked-up by a previously described protocol. The distance between the tumor infiltration front and the resection planes or organ surfaces was documented. The impact of the size of the tumor and an additional portal vein resection was analyzed. The effect of a R1 resection status on development and type of recurrence was evaluated. A total of 203 pancreatic head resections were evaluated. Different definitions of R1 resection were applied. These led to significantly different prognosis for patients. A greater distance between the tumor infiltration front and the resection plane or organ surface was associated with a better outcome for the patients. For the ventral surface, the mesopancreas and the pancreatic body these differences were statistically significant comparing the different R1 definitions. For the dorsal surface, a significant difference in prognosis was found if the tumor was >2 mm away from the resection surface. A tumor size of 3 cm was identified to play a relevant role for the prognosis. Patients who had a portal vein resection without a histologically proven infiltration showed a statistically significant higher overall survival. Patients with R1 resection were at highest risk for developing local recurrence as well as distant metastasis. Intensified histopathological work-up with an increased number of R1 resections has a clinical relevance for patients' prognosis. Tumors with a smaller size or with a greater distance to the organ surface or RM have a better outcome.

Identifiants

pubmed: 31962319
pii: 000504648
doi: 10.1159/000504648
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

265-273

Informations de copyright

© 2020 S. Karger AG, Basel.

Auteurs

Niloufar Dusch (N)

Department of General, Visceral, and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.

Massimo Oldani (M)

Department of General, Visceral, and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.

Tobias Steffen (T)

Department of General, Visceral, and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.

Julia Kitz (J)

Department of Pathology, University Medical Center Goettingen, Goettingen, Germany.

Ute Koenig (U)

Department of Gastroenterology and Gastrointestinal Oncology, University Medical Center Goettingen, Goettingen, Germany.

Azadeh Azizian (A)

Department of General, Visceral, and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.

Alexander König (A)

Department of Gastroenterology and Gastrointestinal Oncology, University Medical Center Goettingen, Goettingen, Germany.

Philipp Ströbel (P)

Department of Pathology, University Medical Center Goettingen, Goettingen, Germany.

Tim Beissbarth (T)

Institute of Medical Bioinformatics, University Medical Center Goettingen, Goettingen, Germany.

Michael Ghadimi (M)

Department of General, Visceral, and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany.

Jochen Gaedcke (J)

Department of General, Visceral, and Pediatric Surgery, University Medical Center Goettingen, Goettingen, Germany, jochen.gaedcke@med.uni-goettingen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH